ORAL ANTIHISTAMINE OR NASAL STEROID IN HAY-FEVER - A DOUBLE-BLIND DOUBLE-DUMMY COMPARATIVE-STUDY OF ONCE DAILY ORAL ASTEMIZOLE VS TWICE DAILY NASAL BECLOMETHASONE DIPROPIONATE

被引：42
|
作者：
WOOD, SF
机构：
来源：
CLINICAL ALLERGY | 1986年 / 16卷 / 03期
关键词：
D O I：
10.1111/j.1365-2222.1986.tb00766.x
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：195 / 201
页数：7
相关论文
共 50 条
  • [41] A double-blind, randomized, crossover dose-response study of the effects of 10, 20, or 40 mg of oral pantoprazole taken once daily on intragastric pH in healthy adults
    Katz, PO
    Paoletti, V
    Bochenek, W
    Steinberg, M
    Castell, DO
    GASTROENTEROLOGY, 1999, 116 (04) : A208 - A208
  • [42] Clinical Efficacy and Safety of Once-Daily Dosing of a Novel, Prolonged-Release Oral Morphine Tablet Compared With Twice-Daily Dosing of a Standard Controlled-Release Morphine Tablet in Patients With Cancer Pain: A Randomized, Double-Blind, Exploratory Crossover Study
    Ridgway, Derry
    Sopata, Maciej
    Burneckis, Arvydas
    Jespersen, Lillian
    Andersen, Christine
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2010, 39 (04) : 712 - 720
  • [43] Safety and Tolerability of NIM-1324, an Oral, Once-daily LANCL2 Agonist, in a Randomized, Double-Blind, Placebo-Controlled Phase 1 Study in Normal Healthy Volunteers
    Leber, Andrew
    Hontecillas, Raquel
    Juni, Nuria Tubau
    Bassaganya-Riera, Josep
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 4631 - 4632
  • [44] Oral Antibiotics for Fever in Low-Risk Neutropenic Patients With Cancer: A Double-Blind, Randomized, Multicenter Trial Comparing Single Daily Moxifloxacin With Twice Daily Ciprofloxacin Plus Amoxicillin/Clavulanic Acid Combination Therapy-EORTC Infectious Diseases Group Trial XV
    Kern, Winfried V.
    Marchetti, Oscar
    Drgona, Lubos
    Akan, Hamdi
    Aoun, Mickel
    Akova, Murat
    de Bock, Robrecht
    Paesmans, Marianne
    Viscoli, Claudio
    Calandra, Thierry
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (09) : 1149 - 1156
  • [45] A MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETY, TOLERABILITY AND CLINICAL ACTIVITY OF ORAL, TWICE-DAILY LTA, PRANLUKAST (SB-206312) IN PATIENTS WITH MILD-TO-MODERATE ASTHMA
    GROSSMAN, J
    BRONSKY, E
    BUSSE, W
    MONTANARO, A
    SOUTHERN, I
    TINKELMAN, D
    DUBB, J
    FAIFERMAN, I
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1995, 95 (01) : 352 - 352
  • [46] Safety and Efficacy of 8-mg Once-daily vs 4-mg Twice-daily Silodosin in Patients With Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (SILVER Study): A 12-Week, Double-blind, Randomized, Parallel, Multicenter Study
    Choo, Myung-Soo
    Song, Miho
    Kim, Jang Hwan
    Lee, Kyu-Sung
    Kim, Joon Chul
    Kim, Sae Woong
    Yang, Sang-Kuk
    Lee, Jeong Gu
    Lee, Jeong Zoo
    Kim, Dae Kyung
    Park, Won Hee
    Kim, Kyung Do
    Na, Yong Gil
    Kwon, Dong Deuk
    Paick, Jae-Seung
    UROLOGY, 2014, 83 (04) : 875 - 881
  • [47] ONCE-DAILY ORAL LUSUTROMBOPAG, ALTERNATIVE TO PLATELET TRANSFUSION IN THROMBOCYTOPENIC PATIENTS WITH CHRONIC LIVER DISEASE UNDERGOING RADIOFREQUENCY ABLATION: RESULTS FROM A PHASE 2B, RANDOMIZED, DOUBLE-BLIND STUDY
    Izumi, N.
    Tateishi, R.
    Seike, M.
    Kudo, M.
    Tamai, H.
    Kawazoe, S.
    Tanaka, K.
    Kurokawa, M.
    Osaki, Y.
    Yamamoto, K.
    Imawari, M.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S386 - S386
  • [48] A 24 MONTHS, PROSPECTIVE, RANDOMISED, DOUBLE-BLIND STUDY TO ASSESS THE EFFECT OF DAILY ORAL ADMINISTRATION OF 2 G OF STRONTIUM RANELATE VS. PLACEBO ON BMD IN POSTMENOPAUSAL OSTEOPOROTIC WOMEN PREVIOUSLY TREATED WITH BISPHOSPHONATES
    Felsenberg, D.
    Chapurlat, R.
    Rizzoli, R.
    Reginster, J-Y.
    Belissa-Mathiot, P.
    OSTEOPOROSIS INTERNATIONAL, 2018, 29 : S262 - S263
  • [49] CHS-131, A Novel Once Daily Oral Treatment, Decreased Lesion Burden of Patients with Relapsing-Remitting Course of Multiple Sclerosis (RRMS) in a Randomized, Double-blind, Phase 2b, Multicenter Study
    Weinstein, David
    Boyko, Alexey
    Pugliese, Lisa
    Tang, Hong
    Lanfear, Dennis
    Zivadinov, Robert
    Finck, Barbara
    NEUROLOGY, 2017, 88
  • [50] Once-daily oral avatrombopag (E5501) prior to elective surgical or diagnostic procedures in patients with chronic liver disease and thrombocytopenia: results from a Phase 2, randomized, double-blind, placebo-controlled study (Study 202)
    Terrault, Norah
    Hassanein, Tarek
    Joshi, Shobha
    Lake, John R.
    Sher, Linda S.
    Vargas, Hugo E.
    McIntosh, Joe W.
    Tang, Shande
    Jenkins, Tim
    HEPATOLOGY, 2012, 56 : 253A - 254A
12345